Phase 2 Study of Zevalin Versus Zevalin and Motexafin Gadolinium in Patients With Rituximab-Refractory Low-grade or Follicular B-cell Non-Hodgkin's Lymphoma
Clinical trial NCT01549886 · TERMINATED
Trial details
- NCT number
- NCT01549886
- Sponsor
- Spectrum Pharmaceuticals, Inc
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2014-06-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.